Bavarian Nordic plans to sharply scale up production of its Jynneos vaccine to prepare for a smallpox emergency, CEO Paul Chaplin said.
"If it wasn't mpox but it was smallpox, we are completely at the wrong scale," Chaplin told CNBC in an interview.
Bavarian Nordic plans to simplify its production process so it can easily partner with other manufacturers and scale up production capacity to hundreds of millions of doses in the event of an emergency.Smallpox was eradicated from the world in 1980 after a successful global vaccination campaign. Though the risk of the virus returning is low, some governments don't want to take any chances.
In the wake of the mpox epidemic, the European Union's Health Emergency Preparedness and Response Authority and at least two European national governments have shown interest in stockpiling the Jynneos vaccine for use against smallpox, Chaplin said. Unlike smallpox, mpox is rarely lethal, but virus can be deadly for people with severely compromised immune systems. And the skin lesions associated with the disease can cause excruciating pain.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Prime Video Nordics Greenlights Study Of ABBA Stalker As First Original Doc; ‘Surviving R. Kelly’ Execs AttachedEXCLUSIVE: Prime Video has been quietly ramping up its Nordic originals slate, and it’s now found its first documentary. We can reveal the streamer’s Nordic arm has ordered Take a Chanc…
Read more »
18 oversold small cap stock picks to buy: Recession investing strategyJEFFERIES: Buy these 18 stocks that are set for outperformance the rest of the year after dropping to long-term low prices
Read more »